ArticleMolecular informatics2012
Annotating Human P-Glycoprotein Bioassay Data.
Article in Molecular informatics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Ligand- and Structure-based Approaches for Transmembrane Transporter Modeling.Current drug research reviews · 2024Review
- EMBL's European Bioinformatics Institute (EMBL-EBI) in 2022.Nucleic acids research · 2023Article
- How Open Data Shapes In Silico Transporter Modeling.Molecules (Basel, Switzerland) · 2017Review
- Empowering pharmacoinformatics by linked life science data.Journal of computer-aided molecular design · 2017Article
- Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds.Molecular diversity · 2016Article
- Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models.Molecular pharmaceutics · 2015Article
- Activity, assay and target data curation and quality in the ChEMBL database.Journal of computer-aided molecular design · 2015Article
- Prediction of drug-ABC-transporter interaction--Recent advances and future challenges.Advanced drug delivery reviews · 2015Review
- Ligand and structure-based classification models for prediction of P-glycoprotein inhibitors.Journal of chemical information and modeling · 2014Article
- How Far Could We Go with Open Data - A Case Study for TRPV1 Antagonists.Molecular informatics · 2013Article
- Comparability of mixed IC₅₀ data - a statistical analysis.PloS one · 2013Article
- PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery.Molecular informatics · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Huge amounts of small compound bioactivity data have been entering the public domain as a consequence of open innovation initiatives. It is now the time to carefully analyse existing bioassay data and give it a systematic structure. Our study aims to annotate prominent in vitro assays used for the determination of bioactivities of human P-glycoprotein inhibitors and substrates as they are represented in the ChEMBL and TP-search open source databases. Furthermore, the ability of data, determined in different assays, to be combined with each other is explored. As a result of this study, it is suggested that for inhibitors of human P-glycoprotein it is possible to combine data coming from the same assay type, if the cell lines used are also identical and the fluorescent or radiolabeled substrate have overlapping binding sites. In addition, it demonstrates that there is a need for larger chemical diverse datasets that have been measured in a panel of different assays. This would certainly alleviate the search for other inter-correlations between bioactivity data yielded by different assay setups.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.